查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1951816

超级崩散剂分析及至2035年预测：依类型、产品、技术、应用、剂型、材料类型、最终用户、功能、製程、模式划分

Superdisintegrants Market Analysis and Forecast to 2035: Type, Product, Technology, Application, Form, Material Type, End User, Functionality, Process, Mode
出版日期: | 出版商: Global Insight Services | 英文 311 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到2034年，超级崩散剂市场规模将从2024年的5.59亿美元成长至9.665亿美元，复合年增长率约为6.1%。超级崩散剂市场涵盖能够促进口服固体製剂崩坏并加速药物释放的物质。主要类型包括合成超级崩解剂、天然超级崩解剂和共加工超级崩散剂，它们对于提高药物生物利用度至关重要。对学名药和新型製剂的需求不断增长是推动市场成长的主要因素。为了满足不断变化的医疗保健需求，创新主要围绕着效率、相容性和合规性。

超级崩散剂市场正经历强劲成长，主要驱动力是市场对速溶药物製剂日益增长的需求。製药业是主要驱动力，其中片剂製剂领域因其在口服给药中的广泛应用而占据主导地位。在众多超级崩散剂中，交联聚维酮和羧甲基淀粉Glico等合成产品因其卓越的功效和与多种药物製剂的相容性而脱颖而出。淀粉和纤维素衍生物等天然系超级崩散剂已成为第二大成长领域，主要得益于人们对天然和永续成分偏好。个人化医疗的进步和新型药物递送系统的开发进一步推动了对超级崩散剂的需求，并带来了创新的商业机会。此外，多功能辅料正逐渐被应用于兼具崩坏和其他功能的领域，有助于提高药物疗效和患者依从性。製剂技术的持续进步预计将继续支撑市场成长。

市场区隔
类型 天然系超级崩散剂、合成超级崩散剂、共加工超级崩散剂
产品 片剂、胶囊
科技 直接压片法、湿式製粒法、干式製粒法
目的 药品和营养补充剂
形状 粉末、颗粒
原料类型 淀粉、纤维素、交联聚乙烯吡咯烷酮（交联聚维酮）、交联羧甲基纤维素钠
最终用户 製药公司、研发机构
功能 崩坏和溶解度
製造过程 生产和配方
模式 口腔崩坏剂，速崩坏剂

超级崩散剂市场参与者众多，造就了其充满活力的市场格局。市场占有率受策略定价和创新产品推出的影响。现有企业正致力于拓展产品系列，以满足製药业不断变化的需求。新型高效超级崩散剂的推出提高了药物製剂的效率，吸引了许多生产商的注意。新进业者寻求透过经济高效的解决方案和先进技术来获取市场份额，进一步加剧了这种竞争格局。在竞争标竿分析方面，主要企业凭藉其创新能力和策略伙伴关係关係脱颖而出。监管影响，尤其是在北美和欧洲，在塑造市场动态发挥关键作用。严格的监管合规性确保了产品的安全性和有效性，从而推动了市场成长。亚太地区已成为一个充满潜力的市场，这得益于其日益增长的製药生产活动。总体而言，在技术进步和监管支援的推动下，预计该市场将实现强劲成长。

主要趋势和驱动因素：

超级崩散剂市场正经历强劲成长，这主要得益于市场对速溶製剂需求的不断增长。这一趋势主要源于患者对更易于服用的剂型的偏好日益增强，尤其是在老年患者和儿童患者中。慢性病发病率的上升以及由此导致的处方药用量增加，进一步推动了对超级崩散剂的需求。药物递送系统的技术进步也对市场产生了显着影响。超级崩散剂製剂的创新提高了活性药物成分的生物利用度和疗效。这一趋势促使製药公司加大研发投入，从而推出新型超级崩散剂产品。监管机构对学名药开发的支持是另一个主要驱动因素。随着多款重磅药物的专利到期，对含有超超级崩散剂剂的、具有成本效益的非专利药的需求不断增长，为市场参与者创造了盈利的机会。此外，人们对个人化医疗的日益关注也推动了客製化超级崩散剂解决方案的发展。这一趋势与精准医疗日益受到重视的理念相符，精准医疗旨在根据患者的个人需求量身定制治疗方案。因此，能够提供创新且适应性强的解决方案的公司更有可能在市场中获得竞争优势。新兴经济体药品生产能力的扩张也带来了进一步的成长机会。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 天然超级崩散剂
    • 合成超级崩散剂
    • 共处理超级崩散剂
  • 市场规模及预测：依产品划分
    • 药片
    • 胶囊
  • 市场规模及预测：依技术划分
    • 直接压缩
    • 湿式製粒
    • 干式製粒
  • 市场规模及预测：依应用领域划分
    • 製药
    • 营养补充品
  • 市场规模及预测：依类型
    • 粉末
    • 颗粒
  • 市场规模及预测：依材料类型划分
    • 淀粉
    • 纤维素
    • 交联聚乙烯吡咯烷酮（交联聚维酮）
    • 交联羧甲基纤维素钠
  • 市场规模及预测：依最终用户划分
    • 製药公司
    • 研究与发展研究所
  • 市场规模及预测：依功能划分
    • 崩坏
    • 溶离度试验
  • 市场规模及预测：依製程划分
    • 製造业
    • 配方
  • 市场规模及预测：按模式
    • 口腔崩坏剂
    • 快速崩坏

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 其他亚太地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章：公司简介

  • DFE Pharma
  • Ashland Global Holdings
  • Roquette Freres
  • FMC Corporation
  • Hunan Er-Kang Pharmaceutical
  • JRS Pharma
  • Asahi Kasei Corporation
  • Avantor Performance Materials
  • Shin-Etsu Chemical Co
  • Dow Du Pont
  • Corel Pharma Chem
  • Anhui Sunhere Pharmaceutical Excipients
  • Maple Biotech
  • NB Entrepreneurs
  • Gangwal Chemicals
  • Blanver
  • Sigachi Industries
  • Rochem International
  • BASF SE

第九章：关于我们

简介目录
Product Code: GIS24900

Superdisintegrants Market is anticipated to expand from $559.0 million in 2024 to $966.5 million by 2034, growing at a CAGR of approximately 6.1%. The Superdisintegrants Market encompasses substances enhancing the disintegration of oral solid dosage forms, accelerating drug release. Key types include synthetic, natural, and co-processed superdisintegrants, crucial in pharmaceuticals for improved bioavailability. Rising demand for generic drugs and novel formulations propels market growth. Innovations focus on efficiency, compatibility, and regulatory compliance to meet evolving healthcare needs.

The Superdisintegrants Market is experiencing robust growth, primarily fueled by the rising demand for fast-dissolving drug formulations. The pharmaceutical sector remains a key driver, with the tablet formulation segment leading the charge due to its widespread application in oral drug delivery. Among superdisintegrants, synthetic variants, such as crospovidone and sodium starch glycolate, stand out as top performers due to their superior effectiveness and compatibility with various drug formulations. Natural superdisintegrants, including starch and cellulose derivatives, are emerging as the second highest performing segment, driven by the increasing preference for natural and sustainable ingredients. The growing trend towards personalized medicine and the development of novel drug delivery systems further propel the demand for superdisintegrants, offering lucrative opportunities for innovation. The market is also witnessing a shift towards multifunctional excipients, which combine disintegration with other functionalities, enhancing drug efficacy and patient compliance. Continuous advancements in formulation technologies are expected to sustain market growth.

Market Segmentation
TypeNatural Superdisintegrants, Synthetic Superdisintegrants, Co-processed Superdisintegrants
ProductTablets, Capsules
TechnologyDirect Compression, Wet Granulation, Dry Granulation
ApplicationPharmaceuticals, Nutraceuticals
FormPowder, Granules
Material TypeStarch, Cellulose, Cross-linked Polyvinylpyrrolidone (Crospovidone), Croscarmellose Sodium
End UserPharmaceutical Companies, Research and Development Institutes
FunctionalityDisintegration, Dissolution
ProcessManufacturing, Formulation
ModeOral Disintegrants, Fast Disintegrants

The Superdisintegrants Market is characterized by a diverse array of players contributing to its dynamic nature. Market share is influenced by strategic pricing and innovative product launches. Established companies are focusing on expanding their product portfolios to cater to the evolving demands of the pharmaceutical industry. The introduction of new, efficient superdisintegrants is enhancing drug formulation efficiency, thereby attracting significant attention from manufacturers. This competitive landscape is further intensified by the entry of new companies, striving to capture market share through cost-effective solutions and advanced technologies. In terms of competition benchmarking, leading firms are differentiated by their innovation capabilities and strategic partnerships. Regulatory influences, particularly in North America and Europe, play a pivotal role in shaping market dynamics. Compliance with stringent regulations ensures product safety and efficacy, driving market growth. The Asia-Pacific region is emerging as a lucrative market, offering significant opportunities due to increasing pharmaceutical manufacturing activities. Overall, the market is poised for robust growth, driven by technological advancements and regulatory support.

Geographical Overview:

The superdisintegrants market is witnessing notable growth across various regions, each presenting unique opportunities. North America leads, driven by a robust pharmaceutical industry and increasing demand for fast-dissolving drug formulations. The region's focus on innovation and advanced drug delivery systems further propels market expansion. Europe follows, with substantial investments in pharmaceutical research and development fostering a conducive environment for superdisintegrant adoption. Asia Pacific emerges as a significant growth pocket, propelled by a burgeoning pharmaceutical sector and rising healthcare expenditures. Countries like India and China are at the forefront, with their expanding generic drug markets and increasing focus on healthcare infrastructure. Latin America and the Middle East & Africa present emerging opportunities, with growing pharmaceutical industries and increasing awareness of advanced drug delivery technologies. Brazil and South Africa are key players in these regions, recognizing the importance of superdisintegrants in enhancing drug efficacy and patient compliance.

The global superdisintegrants market is influenced by tariffs and geopolitical risks, particularly in East Asia. Japan and South Korea are adapting to trade tensions by boosting local production capacities and forming strategic alliances to ensure supply chain resilience. China, facing increased scrutiny and export controls, is focusing on self-reliance and innovation within its pharmaceutical sector. Taiwan's pivotal role in pharmaceutical ingredients is threatened by geopolitical instability, prompting diversification strategies. The parent market, pharmaceuticals, is experiencing robust growth driven by innovation and increasing healthcare demands. By 2035, the superdisintegrants market is expected to evolve with enhanced regional collaboration and technological advancements. Middle East conflicts could disrupt energy prices, indirectly affecting manufacturing costs and supply chain stability across these nations, necessitating adaptive strategies.

Key Trends and Drivers:

The Superdisintegrants Market is experiencing robust growth propelled by the escalating demand for fast-dissolving drug formulations. This trend is largely driven by the increasing preference for patient-friendly dosage forms, particularly among the geriatric and pediatric populations. The rise in chronic diseases and the subsequent increase in prescription medications further fuel the demand for superdisintegrants. Technological advancements in drug delivery systems are significantly impacting the market. Innovations in superdisintegrant formulations enhance the bioavailability and efficacy of active pharmaceutical ingredients. This trend is encouraging pharmaceutical companies to invest in research and development, leading to the introduction of novel superdisintegrant products. Regulatory support for the development of generics is another key driver. As patents for several blockbuster drugs expire, the demand for cost-effective generic formulations incorporating superdisintegrants is rising. This creates lucrative opportunities for market players. Moreover, the growing focus on personalized medicine is fostering the development of customized superdisintegrant solutions. This trend aligns with the increasing emphasis on precision medicine, aiming to tailor treatments to individual patient needs. Consequently, companies that can offer innovative and adaptable solutions are likely to gain a competitive edge in the market. The expansion of pharmaceutical manufacturing capacities in emerging economies presents additional opportunities for growth.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Technology
  • 2.4 Key Market Highlights by Application
  • 2.5 Key Market Highlights by Form
  • 2.6 Key Market Highlights by Material Type
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Process
  • 2.10 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Natural Superdisintegrants
    • 4.1.2 Synthetic Superdisintegrants
    • 4.1.3 Co-processed Superdisintegrants
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Tablets
    • 4.2.2 Capsules
  • 4.3 Market Size & Forecast by Technology (2020-2035)
    • 4.3.1 Direct Compression
    • 4.3.2 Wet Granulation
    • 4.3.3 Dry Granulation
  • 4.4 Market Size & Forecast by Application (2020-2035)
    • 4.4.1 Pharmaceuticals
    • 4.4.2 Nutraceuticals
  • 4.5 Market Size & Forecast by Form (2020-2035)
    • 4.5.1 Powder
    • 4.5.2 Granules
  • 4.6 Market Size & Forecast by Material Type (2020-2035)
    • 4.6.1 Starch
    • 4.6.2 Cellulose
    • 4.6.3 Cross-linked Polyvinylpyrrolidone (Crospovidone)
    • 4.6.4 Croscarmellose Sodium
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Pharmaceutical Companies
    • 4.7.2 Research and Development Institutes
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Disintegration
    • 4.8.2 Dissolution
  • 4.9 Market Size & Forecast by Process (2020-2035)
    • 4.9.1 Manufacturing
    • 4.9.2 Formulation
  • 4.10 Market Size & Forecast by Mode (2020-2035)
    • 4.10.1 Oral Disintegrants
    • 4.10.2 Fast Disintegrants

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Technology
      • 5.2.1.4 Application
      • 5.2.1.5 Form
      • 5.2.1.6 Material Type
      • 5.2.1.7 End User
      • 5.2.1.8 Functionality
      • 5.2.1.9 Process
      • 5.2.1.10 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Technology
      • 5.2.2.4 Application
      • 5.2.2.5 Form
      • 5.2.2.6 Material Type
      • 5.2.2.7 End User
      • 5.2.2.8 Functionality
      • 5.2.2.9 Process
      • 5.2.2.10 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Technology
      • 5.2.3.4 Application
      • 5.2.3.5 Form
      • 5.2.3.6 Material Type
      • 5.2.3.7 End User
      • 5.2.3.8 Functionality
      • 5.2.3.9 Process
      • 5.2.3.10 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Technology
      • 5.3.1.4 Application
      • 5.3.1.5 Form
      • 5.3.1.6 Material Type
      • 5.3.1.7 End User
      • 5.3.1.8 Functionality
      • 5.3.1.9 Process
      • 5.3.1.10 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Technology
      • 5.3.2.4 Application
      • 5.3.2.5 Form
      • 5.3.2.6 Material Type
      • 5.3.2.7 End User
      • 5.3.2.8 Functionality
      • 5.3.2.9 Process
      • 5.3.2.10 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Technology
      • 5.3.3.4 Application
      • 5.3.3.5 Form
      • 5.3.3.6 Material Type
      • 5.3.3.7 End User
      • 5.3.3.8 Functionality
      • 5.3.3.9 Process
      • 5.3.3.10 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Technology
      • 5.4.1.4 Application
      • 5.4.1.5 Form
      • 5.4.1.6 Material Type
      • 5.4.1.7 End User
      • 5.4.1.8 Functionality
      • 5.4.1.9 Process
      • 5.4.1.10 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Technology
      • 5.4.2.4 Application
      • 5.4.2.5 Form
      • 5.4.2.6 Material Type
      • 5.4.2.7 End User
      • 5.4.2.8 Functionality
      • 5.4.2.9 Process
      • 5.4.2.10 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Technology
      • 5.4.3.4 Application
      • 5.4.3.5 Form
      • 5.4.3.6 Material Type
      • 5.4.3.7 End User
      • 5.4.3.8 Functionality
      • 5.4.3.9 Process
      • 5.4.3.10 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Technology
      • 5.4.4.4 Application
      • 5.4.4.5 Form
      • 5.4.4.6 Material Type
      • 5.4.4.7 End User
      • 5.4.4.8 Functionality
      • 5.4.4.9 Process
      • 5.4.4.10 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Technology
      • 5.4.5.4 Application
      • 5.4.5.5 Form
      • 5.4.5.6 Material Type
      • 5.4.5.7 End User
      • 5.4.5.8 Functionality
      • 5.4.5.9 Process
      • 5.4.5.10 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Technology
      • 5.4.6.4 Application
      • 5.4.6.5 Form
      • 5.4.6.6 Material Type
      • 5.4.6.7 End User
      • 5.4.6.8 Functionality
      • 5.4.6.9 Process
      • 5.4.6.10 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Technology
      • 5.4.7.4 Application
      • 5.4.7.5 Form
      • 5.4.7.6 Material Type
      • 5.4.7.7 End User
      • 5.4.7.8 Functionality
      • 5.4.7.9 Process
      • 5.4.7.10 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Technology
      • 5.5.1.4 Application
      • 5.5.1.5 Form
      • 5.5.1.6 Material Type
      • 5.5.1.7 End User
      • 5.5.1.8 Functionality
      • 5.5.1.9 Process
      • 5.5.1.10 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Technology
      • 5.5.2.4 Application
      • 5.5.2.5 Form
      • 5.5.2.6 Material Type
      • 5.5.2.7 End User
      • 5.5.2.8 Functionality
      • 5.5.2.9 Process
      • 5.5.2.10 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Technology
      • 5.5.3.4 Application
      • 5.5.3.5 Form
      • 5.5.3.6 Material Type
      • 5.5.3.7 End User
      • 5.5.3.8 Functionality
      • 5.5.3.9 Process
      • 5.5.3.10 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Technology
      • 5.5.4.4 Application
      • 5.5.4.5 Form
      • 5.5.4.6 Material Type
      • 5.5.4.7 End User
      • 5.5.4.8 Functionality
      • 5.5.4.9 Process
      • 5.5.4.10 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Technology
      • 5.5.5.4 Application
      • 5.5.5.5 Form
      • 5.5.5.6 Material Type
      • 5.5.5.7 End User
      • 5.5.5.8 Functionality
      • 5.5.5.9 Process
      • 5.5.5.10 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Technology
      • 5.5.6.4 Application
      • 5.5.6.5 Form
      • 5.5.6.6 Material Type
      • 5.5.6.7 End User
      • 5.5.6.8 Functionality
      • 5.5.6.9 Process
      • 5.5.6.10 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Technology
      • 5.6.1.4 Application
      • 5.6.1.5 Form
      • 5.6.1.6 Material Type
      • 5.6.1.7 End User
      • 5.6.1.8 Functionality
      • 5.6.1.9 Process
      • 5.6.1.10 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Technology
      • 5.6.2.4 Application
      • 5.6.2.5 Form
      • 5.6.2.6 Material Type
      • 5.6.2.7 End User
      • 5.6.2.8 Functionality
      • 5.6.2.9 Process
      • 5.6.2.10 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Technology
      • 5.6.3.4 Application
      • 5.6.3.5 Form
      • 5.6.3.6 Material Type
      • 5.6.3.7 End User
      • 5.6.3.8 Functionality
      • 5.6.3.9 Process
      • 5.6.3.10 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Technology
      • 5.6.4.4 Application
      • 5.6.4.5 Form
      • 5.6.4.6 Material Type
      • 5.6.4.7 End User
      • 5.6.4.8 Functionality
      • 5.6.4.9 Process
      • 5.6.4.10 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Technology
      • 5.6.5.4 Application
      • 5.6.5.5 Form
      • 5.6.5.6 Material Type
      • 5.6.5.7 End User
      • 5.6.5.8 Functionality
      • 5.6.5.9 Process
      • 5.6.5.10 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 DFE Pharma
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Ashland Global Holdings
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Roquette Freres
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 FMC Corporation
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Hunan Er- Kang Pharmaceutical
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 JRS Pharma
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Asahi Kasei Corporation
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Avantor Performance Materials
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Shin- Etsu Chemical Co
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Dow Du Pont
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Corel Pharma Chem
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Anhui Sunhere Pharmaceutical Excipients
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Maple Biotech
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 NB Entrepreneurs
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Gangwal Chemicals
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Blanver
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Sigachi Industries
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Rochem International
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 BASF SE
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us